文献速递痛风与晶体性关节病

痛风石测量作为结局指标的系统综述更新

Tophus measurement as an outcome measure in gout: an updated systematic literature review.
PubMed 文献 · Semin Arthritis Rheum · 2026-05-15

该研究对2010至2024年痛风石测量方法进行系统检索,并按OMERACT Filter 2.2评估可行性、真实性和区分度。共识别10种方法,游标卡尺在三个维度均有证据支持,是痛风石测量工具的强候选。

要点

  • 游标卡尺与其他物理测量技术相关性好,信度良好至优秀,并显示治疗反应性。
  • 超声和双能CT信度优秀且显示治疗反应性,但尚未在RCT中证明痛风石大小差异。
  • TIQ-20可行性高且显示反应性,但其区分度仍需进一步研究。

核心结论

  • 有证据支持游标卡尺的可行性、真实性和区分度,是痛风石测量工具的强候选。
  • 超声、双能CT和TIQ-20满足Filter的许多方面,但尚未在RCT中证明组间差异。

研究设计与样本

  • 系统检索2010至2024年痛风石评估方法,2010年前文献来自2011年发表的既往综述。
  • 按OMERACT Filter 2.2框架评估每种工具的可行性、真实性和区分度三个维度。

主要发现

  • 共识别10种方法:痛风石计数、卷尺测量、游标卡尺、数字摄影、超声、CT、双能CT、MRI、平片和TIQ-20。
  • 游标卡尺与其他物理测量技术相关性好,信度良好至优秀,并显示治疗反应性和区分度。
  • 超声和双能CT信度优秀且显示治疗反应性,但尚未在RCT中证明痛风石大小差异,且成本和培训要求较高。
  • TIQ-20可行性高且显示反应性,但其区分度需进一步研究。

关键数值与推荐

  • OMERACT Filter 2.2评估可行性、真实性和区分度三个关键维度。
  • 游标卡尺在三个维度均有证据支持。
  • 超声和双能CT信度优秀且显示治疗反应性,但尚未在RCT中证明组间痛风石大小差异。
  • TIQ-20可行性高且显示反应性,区分度待进一步研究。

临床怎么用

  • 游标卡尺可作为痛风石测量的强候选工具,因其在可行性、真实性和区分度上均有证据支持。
  • 超声和双能CT可用于评估痛风石,但需考虑较高成本和培训要求,且缺乏RCT组间差异证据。
  • TIQ-20可作为患者报告结局工具使用,但需注意其区分度证据尚不充分。

局限性

  • 超声和双能CT尚未在RCT中证明痛风石大小差异。
  • TIQ-20的区分度仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct an updated review of methods of tophus measurement in gout and evaluate each method according to the Outcome Measures in Rheumatology (OMERACT) Filter 2.2. METHODS: A systematic search for methods of tophus assessment from 2010 to 2024 was conducted. Publications before 2010 were identified from a previous review published in 2011. Instruments were assessed according to the OMERACT 2.2, a framework for evaluating three key pillars of measurement instruments: their feasibility, truth, and discrimination. RESULTS: Ten methods were identified: counting the number of tophi, tape measurement, Vernier callipers, digital photography, ultrasound (US), computed tomography (CT), dual-energy computed tomography (DECT), magnetic resonance imaging (MRI), plain radiography and the Tophus Impact Questionnaire (TIQ-20), a patient-reported outcome measure. Vernier callipers correlated well with other physical measurement techniques, had good to excellent reliability, and demonstrated responsiveness to treatment and discrimination. US and DECT had excellent reliability and showed responsiveness to treatment but have not yet demonstrated a difference in tophus size in a randomized controlled trial (RCT) and have higher cost and training requirements. The TIQ-20 had high feasibility and demonstrated responsiveness, but further research is required regarding its discrimination. CONCLUSION: There is evidence to support the feasibility, truth and discrimination of Vernier callipers. US, DECT and the TIQ-20 fulfil many aspects of the Filter but have not yet demonstrated a difference between arms of a RCT. Overall, Vernier callipers have evidence for each pillar of the Filter and are a strong candidate for endorsement as an instrument of tophus measurement.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Murdoch R, Pearcy Q, Schauer C, et al. Tophus measurement as an outcome measure in gout: an updated systematic literature review. Semin Arthritis Rheum. 2026. PMID: 42190485. doi:10.1016/j.semarthrit.2026.153000

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。